Diabetes Mellitus: all 11,090 studies

Page 28 of 111. Open to participants first (1,319), then studies with results posted, then the rest; newest registration first within each.

• Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)CompletedNCT01234649Phase 3Results posted
• Impact of Dietary Intervention on Weight Change in Subjects With Type 2 DiabetesCompletedNCT01232491Phase 4Results posted
• Comparison of Glycemic Control in Obese Diabetics Using Three Different Pen NeedlesCompletedNCT01231984Not applicableResults posted
• A Study of Multiple Oral Doses of JNJ-41443532 in Patients With Type 2 Diabetes MellitusCompletedNCT01230749Phase 2Results posted
• Patient Preference and Satisfaction With Insulin Glargine (Lantus) Solostar Pen vs Conventional Vial-Syringe Method of Lantus Injection Therapy in Patients With Type 2 Diabetes MellitusCompletedNCT01226043Phase 4Results posted
• Investigating Re-Dosing With Otelixizumab in Adults With Newly-Diagnosed Type 1 Diabetes MellitusTerminatedNCT01222078Phase 2Results posted
• Diabetes Self-Management Models to Reduce Health DisparitiesCompletedNCT01221090Phase 4Results posted
• Reparixin in Pancreatic Islet TransplantationCompletedNCT01220856Phase 2Results posted
• Dianeal, Extraneal, Nutrineal (D-E-N) Versus Dianeal Only in Diabetic Continuous Ambulatory Peritoneal Dialysis (CAPD) PatientsCompletedNCT01219959Phase 3Results posted
• GWMD1092 - GWP42003 : GWP42004 Together Plus Alone in Type II DiabetesCompletedNCT01217112Phase 2Results posted
• A Dose-Range Finding Study in Participants With Type 2 Diabetes (MK-3102-006)CompletedNCT01217073Phase 2Results posted
• A Study to Evaluate the Effect of LY2189265 on the Speed at Which Food and Drink Leaves the Stomach in Patients With Type 2 Diabetes MellitusCompletedNCT01215968Phase 1Results posted
• Study of Insulin Lispro in Participants With Inadequately Controlled Type 2 DiabetesCompletedNCT01215955Phase 4Results posted
• Comparison of Two Biphasic Insulin Aspart 30 Treatment Regimens in Subjects With Type 2 Diabetes Not Achieving HbA1c Treatment Targets on OADs AloneCompletedNCT01215435Phase 4Results posted
• Use of the FreeStyle Navigator Continuous Glucose Monitoring System to Enhance Education and Glycaemic ControlCompletedNCT01214824Not applicableResults posted
• Efficacy and Safety of Empagliflozin (BI 10773) in Type 2 Diabetes Patients on a Background of Pioglitazone Alone or With MetforminCompletedNCT01210001Phase 3Results posted
• Recombinant Human Leptin Therapy Effects on Insulin ActionCompletedNCT01207934Not applicableResults posted
• A Pilot Study of Hemin Therapy for Gastroparesis (Diabetes Mellitus)CompletedNCT01206582Phase 2Results posted
• Enhancement of Cerebral Vasoreactivity and Cognition by Intranasal Insulin in Type 2 DiabetesCompletedNCT01206322Phase 2Results posted
• Efficacy and Safety of Liraglutide in Subjects With Type 1 Diabetes Undergoing Islet Cell TransplantationTerminatedNCT01206101Phase 2Results posted
• Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 DiabetesCompletedNCT01204775Phase 3Results posted
• Comprehensive Add on Study in JapanCompletedNCT01204294Phase 3Results posted
• Aspirin Dosing in Diabetic PatientsCompletedNCT01201785Phase 4Results posted
• A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive MedicationCompletedNCT01195662Phase 3Results posted
• Adding Sitagliptin or Pioglitazone to Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin and SulfonylureaCompletedNCT01195090Phase 4Results posted
• Efficacy and Safety of Linagliptin (BI 1356) in Black/African Americans With Type 2 Diabetes With a MTT Sub-studyCompletedNCT01194830Phase 3Results posted
• Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes MellitusCompletedNCT01194258Phase 2Results posted
• Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes MellitusCompletedNCT01194245Phase 2Results posted
• Empagliflozin (BI 10773) Dose Finder Study in Japanese Patients With Type 2 Diabetes MellitusCompletedNCT01193218Phase 2Results posted
• Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin/1000 mg Metformin XR (Manufactured in Mt Vernon, IN) Relative to 5 mg of Onglyza and 2 × 500 mg Glucophage XRCompletedNCT01192152Phase 1Results posted
• Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin and 500 mg Metformin XR Tablet (Manufactured in Mt Vernon, IN) Relative to 5 mg Saxagliptin Tablet and 500 mg Metformin XR Tablet (Manufactured in Evansville, IN)CompletedNCT01192139Phase 1Results posted
• Study to Evaluate the Efficacy of Androxal in Controlling Blood Glucose in Men With Type-2 Diabetes MellitusCompletedNCT01191320Phase 2Results posted
• A Study in Participants With Type 2 Diabetes Mellitus (AWARD-4)CompletedNCT01191268Phase 3Results posted
• Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Participants With Type 2 Diabetes Mellitus (MK-0431-251)CompletedNCT01189890Phase 3Results posted
• A Research Trial of Aralast in New Onset Diabetes (RETAIN)TerminatedNCT01183468Phase 1Results posted
• OpT2mise Glucose Control in Type 2 Diabetes Mellitus (DM) With Insulin Pump TherapyCompletedNCT01182493Not applicableResults posted
• Chronic Care Management/Patient Relationship Management Proof of ConceptCompletedNCT01182480Not applicableResults posted
• The Study of Exenatide Action on Vessel Function in Type 2 Diabetes and PrediabetesCompletedNCT01181986Phase 4Results posted
• Remission Evaluation of Metabolic Interventions in Type 2 Diabetes (REMIT Pilot Trial)CompletedNCT01181674Phase 4Results posted
• Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome ResultsCompletedNCT01179048Phase 3Results posted
• Efficacy and Safety of Empagliflozin (BI 10773) Versus Placebo and Sitagliptin Over 24 Weeks in Patients With Type 2 DiabetesCompletedNCT01177813Phase 3Results posted
• Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus Receiving Acarbose Monotherapy (MK-0431-130)CompletedNCT01177384Phase 3Results posted
• Comparison of the Efficacy and Safety of Two Insulin Intensification StrategiesCompletedNCT01175824Phase 4Results posted
• A Study Comparing Insulin Intensification Therapies in Patients With Type 2 Diabetes MellitusCompletedNCT01175811Phase 4Results posted
• Effects of Lixisenatide Compared to Liraglutide on the Postprandial Plasma Glucose in Patients With Type 2 DiabetesCompletedNCT01175473Phase 2Results posted
• Efficacy and Safety of Ranibizumab in Two "Treat and Extend" Treatment Algorithms Versus Ranibizumab As Needed in Patients With Macular Edema and Visual Impairment Secondary to Diabetes MellitusCompletedNCT01171976Phase 3Results posted
• Insulin Dosage Software Program for People With Type 1 and Type 2 DiabetesCompletedNCT01170208Not applicableResults posted
• Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled by MetforminCompletedNCT01169779Phase 3Results posted
• Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 DiabetesCompletedNCT01167881Phase 3Results posted
• The Effect of Aliskiren on Endothelial Function in Pre-Diabetes and DiabetesCompletedNCT01165983Not applicableResults posted
• Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus RegimenCompletedNCT01165684Phase 4Results posted
• Efficacy and Safety of Empagliflozin (BI 10773) in Patients With Type 2 Diabetes and Renal ImpairmentCompletedNCT01164501Phase 3Results posted
• Exploratory Study to Access the Metabolic Effects of Ranolazine in Subjects With Type 2 Diabetes Mellitus When Added to Ongoing Non-insulin Antidiabetic TherapyCompletedNCT01163721Phase 2Results posted
• Integration of Continuous Glucose Monitoring Into a BiHormonal Closed-Loop Artificial PancreasCompletedNCT01161862Not applicableResults posted
• A Study of Postprandial Hyperglycemia in Participants With Type 2 DiabetesCompletedNCT01159938Phase 4Results posted
• Efficacy and Safety Study With Empagliflozin (BI 10773) vs. Placebo as add-on to Metformin or Metformin Plus Sulfonylurea Over 24 Weeks in Patients With Type 2 DiabetesCompletedNCT01159600Phase 3Results posted
• Effects of Pioglitazone on High-density Lipoprotein (HDL) Function in Persons With DiabetesCompletedNCT01156597Phase 3Results posted
• Combination Therapy With Sitagliptin and Lansoprazole to Restore Pancreatic Beta Cell Function in Recent-Onset Type 1 DiabetesCompletedNCT01155284Phase 2Results posted
• Diabetes and Gastric By- PassCompletedNCT01153516Results posted
• Japan Dose Regimen Study of AZD1656 in Japanese Type 2 Diabetes Mellitus PatientsCompletedNCT01152385Phase 2Results posted
• A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 DiabetesCompletedNCT01149421Phase 2Results posted
• Assess the Efficacy of the Low Glucose Suspend (LGS) Feature in the MiniMed Paradigm® X54 SystemCompletedNCT01148862Not applicableResults posted
• Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic PatientsCompletedNCT01147627Not applicableResults posted
• Continuous Glucose Monitoring to Measure Effect of Glycemic IndexCompletedNCT01145547Not applicableResults posted
• Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes MellitusCompletedNCT01144338Phase 3Results posted
• New Ways to Help Patients Improve Their Diabetes ControlCompletedNCT01143870Not applicableResults posted
• Comparative Study of Implant Surfaces to Enhance Stabilization in Patients With Type 2 DiabetesCompletedNCT01142297Not applicableResults posted
• The CANTATA-D2 Trial (CANagliflozin Treatment And Trial Analysis - DPP-4 Inhibitor Second Comparator Trial)CompletedNCT01137812Phase 3Results posted
• A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor BlockerCompletedNCT01137474Phase 3Results posted
• Impact of Exenatide on Sleep in Type 2 DiabetesCompletedNCT01136798Not applicableResults posted
• Effects of Continuous Positive Airway Pressure (CPAP) Treatment on Glucose Control in Patients With Type 2 DiabetesCompletedNCT01136785Not applicableResults posted
• Switching From Insulin Glargine to Insulin Degludec in Subjects With Type 2 Diabetes Mellitus (BEGIN™)CompletedNCT01135992Phase 3Results posted
• Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump UseCompletedNCT01134107Phase 3Results posted
• BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).CompletedNCT01131676Phase 3Results posted
• Study of Sitagliptin Treatment in Patients With Type 2 Diabetes During Ramadan (0431-263)CompletedNCT01131182Phase 4Results posted
• Diabetes in the Elderly: Prospective StudyCompletedNCT01131052Phase 4Results posted
• A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide.CompletedNCT01128894Phase 3Results posted
• A Study in Participants With Type 2 Diabetes Mellitus (AWARD-3)CompletedNCT01126580Phase 3Results posted
• Comparison of the Blood Sugar Lowering Effect of Biphasic Insulin Aspart 30 and Insulin Glargine Both Combined With Metformin and Glimepiride in Chinese and Japanese Subjects With Type 2 Diabetes New to Insulin TreatmentCompletedNCT01123980Phase 4Results posted
• Trial of Otelixizumab for Adolescents and Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-2CompletedNCT01123083Phase 3Results posted
• Diabetes Prevention - Immune ToleranceCompletedNCT01122446Phase 2Results posted
• Management of Diabetes With Metformin In Patients With Chronic Heart FailureCompletedNCT01122316Not applicableResults posted
• Post Marketing Study in Subjects Who Have Type 2 Diabetes Using the EndoBarrier™ Gastrointestinal LinerCompletedNCT01114438Not applicableResults posted
• An Inpatient Performance Evaluation of a New Subcutaneous Glucose SensorCompletedNCT01112696Not applicableResults posted
• Effectiveness and Safety Study of the DexCom™ G4 Continuous Glucose Monitoring SystemCompletedNCT01111370Not applicableResults posted
• Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump UseCompletedNCT01109316Phase 3Results posted
• Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes MedicationsCompletedNCT01107886Phase 4Results posted
• Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DMCompletedNCT01107717Phase 4Results posted
• Mobile Diabetes ManagementCompletedNCT01107015Not applicableResults posted
• The CANTATA-MP Trial (CANagliflozin Treatment and Trial Analysis - Metformin and Pioglitazone)CompletedNCT01106690Phase 3Results posted
• The CANTATA-D Trial (CANagliflozin Treatment and Trial Analysis - DPP-4 Inhibitor Comparator Trial)CompletedNCT01106677Phase 3Results posted
• The CANTATA-MSU Trial (CANagliflozin Treatment And Trial Analysis - Metformin and SUlphonylurea)CompletedNCT01106625Phase 3Results posted
• Reversing Type 1 Diabetes After it is EstablishedCompletedNCT01106157Phase 1/2Results posted
• Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes AdultsCompletedNCT01103284Phase 3Results posted
• Prandial Insulin Dosing in Hospitalized PatientsCompletedNCT01101867Phase 4Results posted
• Ketosis-Prone Diabetes Mellitus (KPDM): Metformin Versus Sitagliptin TreatmentCompletedNCT01099618Phase 4Results posted
• A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.CompletedNCT01098539Phase 3Results posted
• Dose Ranging Study of Albiglutide in Japanese SubjectsCompletedNCT01098461Phase 2Results posted
• Integrating Depression Services Into DM ManagementCompletedNCT01098253Not applicableResults posted
• Study of Safety and Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes And Hypertension (MK-8835-042)CompletedNCT01096667Phase 2Results posted

← Diabetes Mellitus overview